DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.

Simon Peter Gampenrieder , Gabriel Rinnerthaler , Hubert Hackl , Walter Pulverer
Theranostics 8 ( 8) 2278 -2288

16
2018
α/β-Hydrolase Domain Containing Protein 15 (ABHD15) – an Adipogenic Protein Protecting from Apoptosis

Evelyn Walenta , Ariane R. Pessentheiner , Helmut J. Pelzmann , Alexander Deutsch
PLoS ONE 8 ( 11) e79134

7
2013
Next-generation computational tools for interrogating cancer immunity.

Francesca Finotello , Dietmar Rieder , Hubert Hackl , Zlatko Trajanoski
Nature Reviews Genetics 20 ( 12) 724 -746

54
2019
Modeling therapy resistance via the EGFR signaling pathway.

Christina Plattner , Hubert Hackl
FEBS Journal 286 ( 7) 1284 -1286

2019
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.

Sarah Kammerer , Armin Sokolowski , Hubert Hackl , Dieter Platzer
Oncotarget 7 ( 51) 84705 -84717

9
2016
Differential gene expression in Aspergillus fumigatus induced by human platelets in vitro.

Susanne Perkhofer , Christoph Zenzmaier , Emilie Frealle , Michael Blatzer
International Journal of Medical Microbiology 305 ( 3) 327 -338

10
2015
Characterization of the immunophenotypes and antigenomes of colorectal cancers reveals distinct tumor escape mechanisms and novel targets for immunotherapy

Mihaela Angelova , Pornpimol Charoentong , Hubert Hackl , Maria L Fischer
Genome Biology 16 ( 1) 64 -64

284
2015
Clinical Impact of RANK Signalling in Ovarian Cancer.

Verena Wieser , Susanne Sprung , Irina Tsibulak , Johannes Haybaeck
Cancers 11 ( 6) 791

4
2019
Targeting the PD-1/PD-L1 pathway potentiates immunoediting to counterbalance neutral evolution in a mouse model of colorectal cancer

Mirjana Efremova , Victoria Klepsch , Pornpimol Charoentong , Francesca Finotello
bioRxiv 099747

2017
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

Gabriela Bindea , Bernhard Mlecnik , Hubert Hackl , Pornpimol Charoentong
Bioinformatics 25 ( 8) 1091 -1093

5,009
2009
Immunomodulation with pomalidomide at early lymphocyte recovery after induction chemotherapy in newly diagnosed AML and high-risk MDS

Joshua F. Zeidner , Hanna A. Knaus , Amer M. Zeidan , Amanda L. Blackford
Leukemia 34 ( 6) 1563 -1576

14
2020
Abstract P4-07-03: MicroRNAs correlating with outcome in patients treated with first-line bevacizumab for metastatic breast cancer

Simon P Gampenrieder , Frank Hamacher , Gabriel Rinnerthaler , Clemens Hufnagl
Cancer Research 75

2
2015
Transcriptional regulatory program in wild-type and retinoblastoma gene-deficient mouse embryonic fibroblasts during adipocyte differentiation

Robab Hakim-Weber , Anne-M Krogsdam , Claus Jørgensen , Maria Fischer
BMC Research Notes 4 ( 1) 157 -157

14
2011
Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy

Hanna A. Knaus , Sofia Berglund , Hubert Hackl , Amanda L. Blackford
JCI insight 3 ( 21)

52
2018
3D-cultivation of NSCLC cell lines induce gene expression alterations of key cancer-associated pathways and mimic in-vivo conditions

Gabriele Gamerith , Johannes Rainer , Julia M. Huber , Hubert Hackl
Oncotarget 8 ( 68) 112647 -112661

6
2017
The colorectal cancer immune paradox revisited.

Mihaela Angelova , Pornpimol Charoentong , Hubert Hackl , Z. Trajanoski
OncoImmunology 5 ( 2)

9
2016
Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding.

Veronika Thöni , Alexandra Pfister , Andreas Melmer , Barbara Enrich
The Journal of Clinical Endocrinology and Metabolism 102 ( 8) 2974 -2984

18
2017
GPViz: dynamic visualization of genomic regions and variants affecting protein domains

Rene Snajder , Zlatko Trajanoski , Hubert Hackl
Bioinformatics 29 ( 17) 2195 -2196

2
2013
The miR-34 family and its clinical significance in ovarian cancer

Hannah Welponer , Irina Tsibulak , Verena Wieser , Christine Degasper
Journal of Cancer 11 ( 6) 1446 -1456

8
2020